Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.64 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 8/20 | 0.53 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.50 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.50 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CD40 | P25942 | 1/20 | 0.45 |
| ▸ | CD40LG | P29965 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7071374 | 1.00 | PRMT1 (0.68) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL9273205 | 0.89 | PRMT1 (0.73) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL11791675 | 0.89 | PRMT1 (0.73) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL9273197 | 0.89 | PRMT1 (0.73) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL2161281 | 0.88 | PRMT1 (0.74) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL3042237 | 0.88 | PRMT1 (0.74) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL11759436 | 0.87 | CYP1A2 (0.70) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL5859444 | 0.87 | CYP1A2 (0.70) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL29399950 | 0.86 | PRMT1 (0.73) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 | |
| SCHEMBL5351119 | 0.85 | CYP1A2 (0.71) | PRMT1CYP1A2MAPK1CYP2C9DNASE1L3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747704-B1 | Immunoassay element containing a diaryl telluride compound to increase its stability | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2003-12-10 | — | — | EP | disclosed |
| EP-0903583-B1 | Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film immunoassay elements | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2003-11-12 | — | — | EP | disclosed |
| EP-0747702-B1 | Method for washing immunoassay elements | ORTHO CLINICAL DIAGNOSTICS INC (US) | 2003-08-20 | — | — | EP | disclosed |
| EP-0693552-B1 | Analytical element, composition and method using modified apo-horseradish peroxidase | JOHNSON & JOHNSON CLIN DIAG (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-0684473-B1 | Immunoassay elements comprising polymers containing vanadium IV (V (+4)) ions | JOHNSON & JOHNSON CLIN DIAG (US) | 2001-11-07 | — | — | EP | disclosed |
| EP-0718626-B1 | Calibrating and testing immunoassays to minimize interferences | JOHNSON & JOHNSON CLIN DIAG (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-0699908-B1 | Immunoassay elements having stable leuco dye coatings | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-11-22 | — | — | EP | disclosed |
| EP-0699905-B1 | Leuco dye coating compositions | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0603954-B1 | Immunoassay using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer | JOHNSON & JOHNSON CLIN DIAG (US) | 2000-03-08 | — | — | EP | disclosed |
| EP-0903583-A2 | Reduction in first slide bias and improved enzyme stability by incorporation of diaryl tellurides in the gravure layer of dry-film immunoassay elements | Ortho-Clinical Diagnostics, Inc. (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0603962-B1 | Immunoassay elements having a separate receptor layer | JOHNSON & JOHNSON CLIN DIAG (US) | 1999-02-17 | — | — | EP | disclosed |
| US-5714340-A | LAYER CONTAINING LABELED LIGAND, BEAD SPREADING LAYER, CROSSLINKED HYDROPHILIC POLYMER LAYER AND A SUPPORT | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| US-5696193-A | WATER SOLUBLE POLYMER; SPREADING LAYER ON IMMUNOASSAYANALYTICAL ELEMENT | CLINICAL DIAGNOSTIC SYSTEMS, INC. (US) | 1997-12-09 | — | — | US | disclosed |
| US-5516645-A | Immunoassay analytical elements containing vanadium IV(V+4)ions | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5496702-A | TRIARYLIMIDAZOLE DYES, NONIONIC SURFACTANTS | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-03-05 | — | — | US | disclosed |
| EP-0684473-A2 | Immunoassay elements comprising polymers containing vanadium IV (V (+4)) ions | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1995-11-29 | — | — | EP | disclosed |
| EP-0603962-A1 | Immunoassay elements having a seperate receptor layer | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1994-06-29 | — | — | EP | disclosed |